CliffBio
small molecule

VUITY

PILOCARPINE HYDROCHLORIDE

Loss of exclusivityApril 2039latest FDA-listed patent expiry
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameVUITY
Active ingredientPILOCARPINE HYDROCHLORIDE
Strength1.25%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalOctober 2021
Marketing statusDISCN

Listed patents

PatentExpiresType
10610518April 2039use U-3252
11285134April 2039use U-3252

Regulatory exclusivity

CodeExpires
D-187March 2026

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.